The good news: Pharmaceutical companies are developing a range of drugs to treat diseases that are chronic and/or rare. The bad news: Their high (some might say outrageous) cost.
Continue reading “A Bitter Pill: The High Cost of Specialty Drugs”
Continue reading “A Bitter Pill: The High Cost of Specialty Drugs”
As medical technologies and treatments improve, more people are surviving once-fatal forms of cancer, heart disease and other conditions. Many employers have responded to rising costs by increasing their employees’ share of costs. This can leave many employees with staggering healthcare expenses—even if they have medical benefits. Continue reading “Critical Illness Insurance: Filling the Benefits Gap”
In the past ten years, employers have faced skyrocketing costs for their employee health plans. If you have employer-sponsored health coverage, your share of costs has probably risen as a result. Continue reading “How You Can Fill the Benefits Gap”
Almost a third of cancer patients have healthcare costs totaling 10 percent or more of their family income, and roughly one in nine have costs that exceed 20 percent of family income. As a result, 11 percent Continue reading “Critical Illness Insurance Fills a Benefits Gap”